SHIONOGI INC.

ACHIEVED WITH GOOD CHEMISTRY

Pharmaceutical preparations for the treatment of pain, women's health conditions, namely, pharmaceutical preparations for treatment of menstrual symptoms and menopausal conditions; pharmaceutical preparation for treating infections, namely, antibiotic preparations, anti-infectives, and pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treatment of cardiovascular conditions, diabetes, gastrointestinal disorders, and to promote digestion, and pharmaceutical preparations for the treatment of pediatric conditions, namely, ADHD and ADD; medications for pain relief;

ACHIEVED WITH GOOD CHEMISTRY

Wholesale distributorship services featuring pharmaceutical preparations, dietetic and nutritional substances, vitamins, and medications for pain relief;

ALLIANT PHARMACEUTICALS

PHARMACEUTICALS;Development of pharmaceutical preparations and medicines primarily for pediatric and pediatric specialty markets and excluding PFC based products used as contrast agents, oxygen carriers and drug delivery vehicles;

ASCENT

pharmaceutical preparations for the treatment of infections, respiratory diseases, pain, fever, cough, colds, skin diseases, allergies, and gastrointestinal disturbances;

COGNEX

PHARMACEUTICAL PREPARATIONS FOR IMPROVING MEMORY;

DHA 250

Prescription nutritutional supplement for pregnant women and women's health;Color is not claimed as a feature of the mark.;DHA 250;

FORTAMET

In the statement, column 1, line 1, Florida should be deleted, and, Delaware should be inserted.;ANTIDIABETIC PHARMACEUTICAL PREPARATIONS, NAMELY, PHARMACEUTICALS CONTAINING A BIGUANIDE ACTIVE INGREDIENT, NAMELY, METFORMIN;FORT A MET;

HINPERT

Pharmaceutical Products in the Form of an Oral Dosage for the Treatment of Hypertension;The wording HINPERT has no meaning in a foreign language.;

JENLOGA XR

Pharmaceutical Products, in the Form of an Extended Release Oral Dosage for the Treatment of Hypertension, Attention Deficit Hyperactivity Disorders and Other Disorders Characterized by Excessive Autonomic Hyperactivity;XR;

LODINE

The mark consists of the word LODINE on a single horizontal band and two narrower horizontal bands appearing beneath the horizontal band containing the word LODINE. The dotted lines are not a part of the mark and serve only to show the position of the mark on the goods. The placement of the word LODINE on the capsule was distorted slightly so that the whole word LODINE could be depicted as two dimensional.;Analgesic and anti-inflammatory preparations;Color is not claimed as a feature of the mark.;